5-HTP | 5-Hydroxytryptophan |
AD | Activator domain |
ASM | Anti-seizure medication |
CaLexA | Calcium-dependent nuclear import of LexA |
CaM | Calmodulin |
CaMPARI | Calcium-modulated photoactivatable ratiometric integrator |
cDNA | Complementary DNA |
CRIMIC | CRISPR MiMIC |
CRISPR | Clustered regularly interspaced short palindromic repeats |
DBD | DNA-binding domain |
DEE | Developmental and epileptic encephalopathy |
DREADDs | Designer receptors exclusively activated by designer drugs |
DS | Dravet syndrome |
ERG | Electro-retinogram |
GECI | Genetically encoded calcium indicator |
GEFS+ | Generalized epilepsy with febrile seizures plus |
GF | Giant-fiber |
GOF | Gain-of-function |
HDR | Homology-directed repair |
LOF | Loss-of-function |
MiMIC | Minos mediated integration cassette |
NFAT | Nuclear factor of activated T-cells |
NHEJ | Non-homologous end joining |
ORF | Open reading frame |
PTX | Picrotoxin |
PTZ | Pentylenetetrazol |
RMCE | Recombination mediated cassette exchange |
RNAi | RNA interference |
TRIC | Transcriptional reporter of intracellular Ca2+ |
UAS | Upstream activating sequence |